{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:57:41Z","timestamp":1790841461656,"version":"4.1.0"},"reference-count":15,"publisher":"American Association for Cancer Research (AACR)","issue":"10","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:title>Summary:<\/jats:title>\n                  <jats:p>Despite strong preclinical evidence, ferroptosis-based strategies have not yet translated into the clinic, in part due to the disconnect between conventional in vitro models and the complex tumor microenvironment. In this commentary, we consider ferroptosis as a microenvironmentally regulated process and call for multidisciplinary approaches that bridge foundational ferroptosis biology with clinically actionable interventions grounded in the context of the tumor microenvironment.<\/jats:p>","DOI":"10.1158\/2159-8290.cd-26-0232","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:11:42Z","timestamp":1790838702000},"page":"1967-1972","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Studying Ferroptosis in the Tumor Microenvironment"],"prefix":"10.1158","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7673-4842","authenticated-orcid":false,"given":"Marie","family":"Sabatier","sequence":"first","affiliation":[{"name":"1Department of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, Massachusetts."},{"name":"2Ludwig Center at Harvard, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7855-9125","authenticated-orcid":false,"given":"Jessalyn M.","family":"Ubellacker","sequence":"additional","affiliation":[{"name":"1Department of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, Massachusetts."},{"name":"2Ludwig Center at Harvard, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"2026100103113767400_bib1","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"2026100103113767400_bib2","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1038\/s43018-025-01037-7","article-title":"Prospects for ferroptosis therapies in cancer","volume":"6","author":"Ubellacker","year":"2025","journal-title":"Nat Cancer"},{"key":"2026100103113767400_bib3","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1038\/s41568-025-00864-1","article-title":"Decoding ferroptosis for cancer therapy","volume":"25","author":"Wahida","year":"2025","journal-title":"Nat Rev Cancer"},{"key":"2026100103113767400_bib4","doi-asserted-by":"publisher","first-page":"eadq7305","DOI":"10.1126\/sciadv.adq7305","article-title":"Identifying metabolic limitations in the tumor microenvironment","volume":"10","author":"Cognet","year":"2024","journal-title":"Sci Adv"},{"key":"2026100103113767400_bib5","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/s41580-025-00843-2","article-title":"Recommendations for robust and reproducible research on ferroptosis","volume":"26","author":"Mishima","year":"2025","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2026100103113767400_bib6","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.cmet.2008.07.005","article-title":"Glutathione peroxidase 4 senses and translates oxidative stress into 12\/15-lipoxygenase dependent- and AIF-mediated cell death","volume":"8","author":"Seiler","year":"2008","journal-title":"Cell Metab"},{"key":"2026100103113767400_bib7","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/s41589-020-0613-y","article-title":"Metabolic determinants of cancer cell sensitivity to canonical ferroptosis inducers","volume":"16","author":"Soula","year":"2020","journal-title":"Nat Chem Biol"},{"key":"2026100103113767400_bib8","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","article-title":"FSP1 is a glutathione-independent ferroptosis suppressor","volume":"575","author":"Doll","year":"2019","journal-title":"Nature"},{"key":"2026100103113767400_bib9","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","article-title":"The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis","volume":"575","author":"Bersuker","year":"2019","journal-title":"Nature"},{"key":"2026100103113767400_bib10","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41586-025-08974-4","article-title":"Activation of lysosomal iron triggers ferroptosis in cancer","volume":"642","author":"Ca\u00f1eque","year":"2025","journal-title":"Nature"},{"key":"2026100103113767400_bib11","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41586-025-09162-0","article-title":"Glycosaminoglycan-driven lipoprotein uptake protects tumours from ferroptosis","volume":"644","author":"Calhoon","year":"2025","journal-title":"Nature"},{"key":"2026100103113767400_bib12","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41556-026-01879-y","article-title":"Tumour acidosis remodels the glycocalyx to control lipid scavenging and ferroptosis","volume":"28","author":"B\u00e5ng-Rudenstam","year":"2026","journal-title":"Nat Cell Biol"},{"key":"2026100103113767400_bib13","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41586-025-09709-1","article-title":"Lymph node environment drives FSP1 targetability in metastasizing melanoma","volume":"649","author":"Palma","year":"2026","journal-title":"Nature"},{"key":"2026100103113767400_bib14","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1038\/s41467-022-31218-2","article-title":"Cancer cells dying from ferroptosis impede dendritic cell-mediated anti-tumor immunity","volume":"13","author":"Wiernicki","year":"2022","journal-title":"Nat Commun"},{"key":"2026100103113767400_bib15","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41586-025-09710-8","article-title":"Targeting FSP1 triggers ferroptosis in lung cancer","volume":"649","author":"Wu","year":"2026","journal-title":"Nature"}],"container-title":["Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/16\/10\/1967\/3832721\/cd-26-0232.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/16\/10\/1967\/3832721\/cd-26-0232.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:11:42Z","timestamp":1790838702000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article\/16\/10\/1967\/788519\/Studying-Ferroptosis-in-the-Tumor"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":15,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10,1]]},"published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2159-8290.cd-26-0232","relation":{},"ISSN":["2159-8274","2159-8290"],"issn-type":[{"value":"2159-8274","type":"print"},{"value":"2159-8290","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]}}}